<DOC>
	<DOC>NCT00623116</DOC>
	<brief_summary>Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.</brief_summary>
	<brief_title>A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland</brief_title>
	<detailed_description>Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror movements, hearing loss and infertility. Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kallmann Syndrome</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Estrone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estropipate</mesh_term>
	<criteria>Kallmann syndrome Age 15 yrs or more Severe mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Kallmann Syndrome</keyword>
	<keyword>hypogonadotropic hypogonadism</keyword>
</DOC>